Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Koopmans

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|October 14, 2006
A retrospective TDM database analysis of interpatient variability in the pharmacokinetics of lopinavir in HIV-infected adultsMartijn R van der Leur, David M Burger, Charles J L la Porte, et al.
Antiviral Therapy|January 25, 2006
Role of the inhibitory quotient in HIV therapyJolando G M Hoefnagel, Peter P Koopmans, David M Burger, et al.
Clinical Pharmacology and Therapeutics|December 13, 2005
Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteersRob E Aarnoutse, Johanneke Kleinnijenhuis, Peter P Koopmans, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2002
Pharmacokinetic variability caused by gender: do women have higher indinavir exposure than men?David M Burger, Marijke C Siebers, Patricia W H Hugen, et al.
Antiviral Therapy|May 11, 2011
Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavirClara T M M de Kanter, Monique Keuter, Manon J van der Lee, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2010
No changes in efavirenz plasma concentrations in HIV-infected patients who switch from Stocrin to AtriplaDavid Burger, Matthijs van Luin, Marjolein Bosch, et al.
AIDS (London, England)|November 7, 2015
Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapyMarloes A M Janssen, Olga Meulenbroek, Stefan C A Steens, et al.
Therapeutic Drug Monitoring|September 28, 2002
Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliancePatricia W H Hugen, David M Burger, Rob E Aarnoutse, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 20, 2002
Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoringPatricia W H Hugen, Nienke Langebeek, David M Burger, et al.
Sexually Transmitted Diseases|February 14, 2013
A patient with multifocal tabetic arthropathy: a case report and review of literatureMaaike Schotanus, Desirée M J Dorleijn, Allard J F Hosman, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|October 14, 2006
A retrospective TDM database analysis of interpatient variability in the pharmacokinetics of lopinavir in HIV-infected adultsMartijn R van der Leur, David M Burger, Charles J L la Porte, et al.
Antiviral Therapy|January 25, 2006
Role of the inhibitory quotient in HIV therapyJolando G M Hoefnagel, Peter P Koopmans, David M Burger, et al.
Clinical Pharmacology and Therapeutics|December 13, 2005
Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteersRob E Aarnoutse, Johanneke Kleinnijenhuis, Peter P Koopmans, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2002
Pharmacokinetic variability caused by gender: do women have higher indinavir exposure than men?David M Burger, Marijke C Siebers, Patricia W H Hugen, et al.
Antiviral Therapy|May 11, 2011
Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavirClara T M M de Kanter, Monique Keuter, Manon J van der Lee, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2010
No changes in efavirenz plasma concentrations in HIV-infected patients who switch from Stocrin to AtriplaDavid Burger, Matthijs van Luin, Marjolein Bosch, et al.
AIDS (London, England)|November 7, 2015
Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapyMarloes A M Janssen, Olga Meulenbroek, Stefan C A Steens, et al.
Therapeutic Drug Monitoring|September 28, 2002
Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliancePatricia W H Hugen, David M Burger, Rob E Aarnoutse, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 20, 2002
Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoringPatricia W H Hugen, Nienke Langebeek, David M Burger, et al.
Sexually Transmitted Diseases|February 14, 2013
A patient with multifocal tabetic arthropathy: a case report and review of literatureMaaike Schotanus, Desirée M J Dorleijn, Allard J F Hosman, et al.
Pageof 5